← Every company
Coherus Oncology Inc SEC Filings
What Coherus Oncology Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
CHRS overview →Filings on file
160
since Sep 26, 2016
Warning signs
3
latest Jun 15, 2026
Last results
Aug 5, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Apr 25, 2025 | Executive or director change 8-K | Read ↗ |
| Apr 22, 2025 | Executive or director change 8-K | Read ↗ |
| Dec 4, 2024 | Executive or director change 8-K | Read ↗ |
| Aug 8, 2024 | Executive or director changeResults announced 8-K | Read ↗ |
| Jun 5, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 22, 2024 | Executive or director change 8-K | Read ↗ |
| Dec 11, 2023 | Executive or director change 8-K | Read ↗ |
| Dec 7, 2023 | Executive or director change 8-K | Read ↗ |
| Jul 20, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 6, 2023 | Executive or director changeResults announcedRestructuring 8-K | Read ↗ |
| Sep 9, 2022 | Executive or director change 8-K | Read ↗ |
| May 13, 2022 | Executive or director change 8-K | Read ↗ |
| May 10, 2022 | Executive or director change 8-K | Read ↗ |
| Feb 7, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 3, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 13, 2021 | Executive or director change 8-K | Read ↗ |
| Sep 29, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 11, 2021 | Executive or director change 8-K | Read ↗ |
| May 26, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 12, 2021 | Executive or director change 8-K | Read ↗ |
| Jan 7, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 18, 2020 | Executive or director change 8-K | Read ↗ |
| Aug 6, 2020 | Executive or director change 8-K | Read ↗ |
| May 14, 2018 | Executive or director change 8-K | Read ↗ |
| Mar 6, 2018 | Executive or director change 8-K | Read ↗ |
| Apr 10, 2017 | Executive or director change 8-K | Read ↗ |
Source: Coherus Oncology Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on CHRS
Company overviewEverything on CHRS in one place, with the price.Executive payWhat CHRS awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in CHRS.Funds holding itWhich funds and ETFs hold CHRS, and how big a bet.PatentsWhat CHRS is filing at the patent office.